The InPen Smart Insulin Pen helps patients on multiple daily injection (MDI) therapy take the right amount of insulin at the right time with the help of real-time tracking and dosing support. The InPen Insights Reports empowers the provider like never before, with actionable and tangible data to help advise therapy adjustments for patients utilizing MDI.
InPen automatically records the amount and time of each insulin dose and wirelessly transmits the information to the InPen app. The InPen app then prepares shareable Insights Reports. There are two options for the InPen user to share the Insights Reports with their healthcare provider (HCP).
It’s that simple! Keep in mind, regardless of the option the patient uses to share their data, the HCP will have visibility into the their glucose and insulin management data. That said, with this new integration between the InPen Insights Reports and CareLink™ software, the conversation and data sharing experience between the HCP and the InPen user has never been easier.
Need help? We’ve got you covered with step-by-step instructions on how to link InPen Insights Reports in Carelink™ system. For any additional questions, please contact your local Medtronic Diabetes representative.
Important safety information: InPen™
The InPen requires a prescription. It is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPen dose calculator, a component of the InPen app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data.
For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use.
For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use.
For additional product and important safety considerations, see User Guide and http://bit.ly/InPenSafety
Important safety information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult http://www.medtronicdiabetes.com/ImportantSafetyInformation and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides